I tend to agree that at the present level of valuation and the current sentiment towards covid stocks, SNG is now in a less favorable risk/ reward ratio than before … SNG is the number one stock for many of the new ´ covid ´ investors and has a major cult following but it reminds me ( a bit too much ) of IMM before P3 read outs ( but without the company ramping ) The major factor one has to take into account is what has SNG to fall back on in case the P3 trials don’t live up to expectations ?
Worth a punt but one has to be aware of their money management and be prepared to lose 50-70% of the investment if things go bad …
One can lose profits , that’s not a problem but when one loses their capital well that’s a different story so be safe …